INTRODUCTION
'It is likely that tuberculosis will be virtually eradicated in most technically advanced countries during the first half of the next century'. This was the optimistic prediction of the Oiford Textbook ifMedicine in 1987 1 • Now in 1996 the future is less certain. The decline of tuberculosis in Western countries has slowed and in some places has been reversed. Multidrug resistance has appeared and in the developing world tuberculosis remains unchecked.
Infection by the tubercle bacillus shows three important features. First, symptomatic disease may be due to the reactivation of quiescent infection, so that the incidence of tuberculosis reflects past events. Second, drug resistance arises from stepwise gene mutations coding for drug targets 2 ; it is therefore either poor compliance or poor prescribing which allows resistant mutants to develop. Third, tuberculosis is associated with social deprivation and is inextricably linked with political issues. In this article I discuss the changing incidence of tuberculosis and some of the factors which have influenced these changes. I also try to look into the future, but whether my predictions will be more successful than those of the Oiford Textbook ifMedicine is doubtful.
TRENDS NORTH AND SOUTH
In developed countries the incidence of tuberculosis declined from the turn of the century. This decline sharpened after the introduction of anti-tuberculous drugs in the 1950s. A Medical Research Council (MRC) study of notifications in England and Wales for 1988 showed a rate of just under 10 per 100 000 3 and in 1990 the total number of deaths attributed to tuberculosis had dropped to 49()4. The fall was slowed by immigration from countries where tuberculosis is common, thus the notification rate among the indigenous population in 1988 was 4.7 per 100000, whereas among immigrants from the Indian subcontinent (the largest immigrant group) the rate was 120 per 100000. However, the rate of decline was similar in both groups at 6%--7% per annuml, An important finding of the MRC study was that in the indigenous population the notification rate rose with age 3 , reflecting a high infection rate in the 1920s and 1930s when St George's Hospltel, London SW17 oaT, England the condition was common and anti-tuberculous drugs had not arrived. In these elderly patients quiescent disease became active as the immune response deteriorated with age. Subsequent cohorts were less likely to be infected, and as the older generation disappears the incidence will fall still further. It was therefore reasonable to suppose that the condition could be virtually eradicated in the forseeable future. However, in the 1980s there was an unexpected change which was seen most dramatically in the USA.
Up to 1985 the situation in the USA was similar to that in the UK 5 . However, from 1985 to 1992 there was an increase of 20.1 %6, affecting mainly urban areas and in particular New York. In Central Harlem the incidence rose to over 150 per 100000 7 . In absolute numbers, the increase was 22201 to 26673 which, in relation to the estimated world total of 8 million new cases per annum, is not vast. Much more alarming was the appearance of multidrug resistant organisms (organisms resistant to at least rifampicin and isoniazid), which approached 20% in New York isolates 8 ,9. A review of the patients with resistant organisms showed that these were predominantly men under 40, from minority groups, unemployed, homeless, and with a high prevalence of drug abuse and HIV infection", A history of previous anti-tuberculous drug treatment was the strongest predictor of drug resistances. The mortality rate among patients infected with resistant organisms was high, even among those who complied with treatmentl'', and the organisms were shown to spread rapidly, particularly to patients with HIV infection11,12. Increased funding, with the introduction of supervised chemotherapy (every dose seen to be taken), has been successful in reducing the overall incidence of tuberculosis'J and the rate of drug resistance in new cases!".
In the UK the number of notifications of tuberculosis has risen l S . However, the disease was formerly undernotified l 6-18, and some of the increase is due to improved notification rates rather than an increase in Incidence!". Nevertheless, notifications exceed predictions'f and there probably has been a real increase, particularly in urban areas. One outbreak of hospital acquired multidrug resistance has occurred in an HIV unit in London/", but so far drug resistance has not been a serious problem-". Other western European countries report similar experience, though there may be substantial under-reporting in some 22 • As in New York, there is the potential for development of multidrug resistance among the marginalized populations of cities. In eastern Europe and the former Soviet Union notification rates are higher, varying from 19 to 80 per 100 000. Drug resistance is recorded but the information is sketch y 22,23. In contrast to the Western world, which has the resources and skills to control tuberculosis, the situation in developing countries is very grave and the interaction between AIDS and tuberculosis presents an appalling problem.
The World Health Organization estimates that one-third of the world's population carry the tubercle bacillus-half in industrialized countries and the other half in the less developed world. The critical difference between the two groups is their age. Fewer young people in the West carry the bacillus and 80% of infected individuals are over the age of 50, whereas in the less developed countries 75% are under 50 24 . Thus the AIDS virus has appeared at a time when in the developing world most of the young adults who are likely to be infected with the virus have also been infected with the tubercle bacillus. Of the 8 million new cases of tuberculosis in 1990, some 95% were in the less developed world. The total deaths worldwide were just under 3 million, making tuberculosis the largest single killer of all the infectious diseases and accounting for 26% of avoidable adult deaths 24,25. There have been reports of multidrug resistance-s but in many places there are no facilities for measuring resistance and its prevalence is unknown.
WHY THE INCREASE IN INCIDENCE?
The major factors that have increased the incidence of tuberculosis are AIDS, social deprivation, lack of resources, poor administration, migration and neglect. It is difficult to disentangle their relative importance because they so often occur together.
HIV infection
HIV destroys the immune system and is the most important risk factor for the reactivation of latent tuberculosis-f. In sub-Saharan Africa most people are infected with tuberculosis/? although they may not have overt disease. The estimated total number of cases of adult HIV infection worldwide is 18 million. Of these, 11 million are in sub-Saharan Africa 28. HIV increases the incidence of tuberculosis not only by reactivating infection but also by increasing the number of infectious cases?". The largest concentrations of people with tuberculosis are in Asia and the Western Pacific and only one-tenth live in Africa. However, because of the high prevalence of HIV in Africa, there could be up to a 12fold increase in tuberculosis by the year 2000 30 and an increase in HIV infection in Asia and the Pacific to the levels seen in sub-Saharan Africa will have a catastrophic effect. In New York AIDS has been a major risk factor 7,8. However, in the UK the overlap between the populations with HIV infection (young white males) and the population with previous tuberculous infection (older people and immigrants from the Indian subcontinent) is limited and at present only about 5% of patients with AIDS have tuberculosistl.
Social deprivation
Investigations in Liverpool and London have shown a high correlation with poverty32,33 and in the Bronx tuberculosis in children was closely correlated with overcrowding. The prevalence rose from 1.47 to over 8 cases per 10000 as overcrowding increased'". Similar results have been obtained among children in Leeds 35 and among the homeless in London-". Vagrancy, drug addiction, and alcoholism? all contribute. The socially deprived are often forced to live in hostels, shelters, and prisons where infection can spread and conditions make compliance with prolonged chell,1otherapy difficult 7,37. In less developed countries, where the germ theory of disease is often not understood, it is difficult to explain to patients why they should take drugs for a long time after their symptoms have improved.
Lack of resources
Lack of resources is a limiting factor in many countries, although anti-tuberculous regimens can be highly cost effective-".
Poor administration
Administrative errors are well documented in New York. As the incidence fell, funding was withdrawn and tuberculosis clinics closed. There were errors of management 39 and patients were inadequately supervised. For example, of 178 patients on anti-tuberculous drugs, 89% were lost and did not complete their treatment and 48 were readmitted within one year with active disease. Of these, 40 were discharged again on treatment and no fewer than 35 were lost for a second time.? The cost of these errors is enormous. The average cost of 'salvage therapy' is estimated at $180000 per patient 39. The maintenance of a chest clinic service with staff who have specific responsibility for the control of tuberculosis is probably the main reason why such disasters have not happened in the UK. Nevertheless, surveillance has often been lackadaisical, as demonstrated by the high rates of under-notification16,17.
Migration
Immigration from countries with a high incidence has been an important factor in Western countries that have accepted immigrants. However, provided that a chest clinic service is maintained, infection can be contained! (see above). The mass movement of refugees in time of war is much more troublesome, as demonstrated by a small study from Croatia''".
Neglect
This is the most important factor of all. The developing world is neglected. The epidemic of tuberculosis in New York was among the neglected members of society. There are, however, less obvious forms of neglect. Although new drugs are urgently needed, both to treat patients with resistant organisms and to reduce the length of treatment, research and development in this area has low priority. The reason is that the costs of drug development are high, there would be no large market in the West, and the developing world is unable to afford new drugs. Therefore a drug company making a new anti-tuberculous drug would not make a profit. There is therefore an urgent need for an international body to raise funds for drug developmentt'. Finally, patients with tuberculosis themselves tend to be neglected, particularly in less developed countries. In general, tuberculosis is not difficult to diagnose or treat, but requires attention to detail, a constant supply of drugs, and careful follow-up. However, it does not have the immediate demand of emergency medicine and, when medical personnel are short, emergencies take priority and the tuberculosis programme is left to fend for itself. Nor does it have the charisma of high technology: instead of investing in the transport required for a rural tuberculosis service, countries buy equipment for expensive operating theatres where there is no surgeon 42 . The world is faced with the disastrous interaction between tuberculosis and HIV and the potential tragedy of the spread of multidrug resistance. The Oiford Textbook would be right to say tuberculosis could be eradicated in technically advanced countries during the first half of the next century. Tuberculosis could be eradicated from the whole world, although this might take a little longer. The stumbling blocks are the ever widening gap between rich and poor and the failure to implement properly run regimens of chemotherapy.
